I Review Mattresses for a Living. This Is What I Sleep on at Home
OK, enough shop talk. Here's what I like from testing this mattress. I remember when Nolah first launched the Evolution back in 2020, and it was touted as a good option for side sleepers with all the pressure relief and lumbar support features. When I eventually tried it (and various iterations afterward), it consistently delivered on these marks. Something that has always stood out to me as a major value add was the three firmness options available: plush, luxury firm, and firm. Having a variety of firmnesses is an easy way to make a mattress more accessible to all kinds of sleepers, especially with different body types and sleeping positions.
I landed on 'luxury firm' for a couple of reasons, chief among them being that I'm part of a dynamic sleeping duo. In other words, my husband is a back sleeper, and I'm a stomach sleeper (who is desperately trying to be a side sleeper, mind you). All to say, these sleeping positions can require different firmness levels for adequate support, preferences not even being factored in. Luxury firm is the middle ground, and we've found it to be a welcoming amount of softness that doesn't cancel out the feeling of support.
While I'm on my side, my hips and shoulders get hugged, and if I'm on my stomach, my lower back stays lifted. Everything remains relatively on the same level—hips, lower back, and shoulders—which is what you want for even spine alignment. When on your back, your spine curves away from the bed, but the pillow top takes up that space nicely. That way your back doesn't feel like it's being left out support-wise, and this eliminates a potential cause of back pain.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
BrightSpring Health Services Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
BrightSpring Health Services (NASDAQ:BTSG) Second Quarter 2025 Results Key Financial Results Revenue: US$3.15b (up 15% from 2Q 2024). Net income: US$9.21m (down 54% from 2Q 2024). Profit margin: 0.3% (down from 0.7% in 2Q 2024). EPS: US$0.046 (down from US$0.10 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period BrightSpring Health Services Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 5.3%. Earnings per share (EPS) missed analyst estimates by 9.3%. Looking ahead, revenue is forecast to grow 10.0% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Healthcare industry in the US. Performance of the American Healthcare industry. The company's shares are down 4.3% from a week ago. Risk Analysis What about risks? Every company has them, and we've spotted 3 warning signs for BrightSpring Health Services (of which 1 is a bit unpleasant!) you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
40 minutes ago
- Yahoo
3 Reasons to Buy Medtronic Stock
Key Points Medtronic is separating out its lower-margin diabetes care segment. It's also pouncing on a massive opportunity in robotic-assisted surgery. The healthcare leader has a terrific dividend-growth track record. 10 stocks we like better than Medtronic › Medical device specialist Medtronic (NYSE: MDT) has not been the best of investments over the past five years. The stock has significantly lagged the market over this period, thanks to weak business fundamentals, including slow revenue growth. The healthcare giant now faces additional obstacles, such as the threat of steeper tariffs due to President Donald Trump's aggressive trade policies. Even amid all that, Medtronic has plenty of redeeming qualities and could still be a solid investment for long-term investors. Here are three reasons why. 1. Medtronic is spinning off its diabetes care unit Medtronic recently announced that it will be spinning off its diabetes care unit, which will become a stand-alone, publicly traded company. Although sales of diabetes products have been growing faster than the rest of Medtronic's business, they have also been a drag on margins. During the company's fiscal year 2025, which ended on April 25, diabetes care accounted for 8% of revenue but only 4% of operating profits. Medtronic's other segments are not growing their sales as quickly, but they have more profitable margins. In an environment where the company may face higher manufacturing costs due to tariffs, management has chosen to focus on higher-margin opportunities. Diabetes care was also the healthcare specialist's only consumer-facing business; the others offer products to healthcare providers. The move could help Medtronic navigate the macroeconomic landscape better if Trump's tariffs remain in place. That's especially the case if the company can find other lucrative revenue growth opportunities. 2. A significant opportunity in robotic-assisted surgery Medtronic has been developing its robotic-assisted surgery (RAS) system, Hugo, for years. It has been in use in other countries, though it's yet to get the regulatory nod in the United States. The medical device specialist decided to pursue this opportunity because the RAS market is severely underpenetrated. Intuitive Surgical's da Vinci system dominates the field and faces little competition for the range of procedures for which it's approved. Yet a couple of years ago, Medtronic pointed out that of all the procedures that could be performed robotically, fewer than 5% were. And over the long run, the demand for these kinds of surgeries will increase along with the world's aging population, since seniors are far more likely to face health issues that call for these kinds of interventions. The good news is that Medtronic's Hugo system recently completed clinical trials in the U.S. for urologic procedures. The company has requested clearance from the U.S. Food and Drug Administration for that indication. It should be the first of many. The Hugo system could eventually become a crucial part of Medtronic's growth strategy and help improve its financial results over the long term, given the significant white space available in the industry. 3. A soon-to-be Dividend King Despite Medtronic's recent challenges, the company has continued to pay and raise its dividends. In fact, the company has raised dividends for 48 consecutive years. Most businesses don't survive nearly five decades, let alone pay dividends for that long. Medtronic's ability to do so speaks volumes about its underlying business. It's a well-established leader in its niche of the healthcare market, with significant footprint in the industry and a long and successful history of navigating this deeply regulated sector. All of those factors make Medtronic an excellent pick for income-seeking investors. It should continue rewarding shareholders with payout increases for a long time -- and in two years, it should become a Dividend King. Medtronic may not be one of the most exciting artificial intelligence (AI) leaders capturing Wall Street's attention, although the company is implementing AI across its business in ways that could pay off in the long run. Regardless, its recent moves in shedding its diabetes care segment and seeking clearance for its Hugo system, along with its consistent dividend streak, make Medtronic a reliable company to invest in for the long haul. Do the experts think Medtronic is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Medtronic make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,019% vs. just 178% for the S&P — that is beating the market by 841.12%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Prosper Junior Bakiny has positions in Intuitive Surgical. The Motley Fool has positions in and recommends Intuitive Surgical. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy. 3 Reasons to Buy Medtronic Stock was originally published by The Motley Fool
Yahoo
40 minutes ago
- Yahoo
63 million adults are moonlighting as caregivers, with little support
Two years ago, Anita Robinson took early retirement from her position as a senior partner at a tech firm in Atlanta. She was 57 and had been at the company for more than three decades. 'It wasn't my intent, but special circumstances called me to duty as a daughter,' Robinson told me. Her 83-year-old mom is blind, has dementia, four different types of cancer, and requires full-time care. 'I just couldn't in good conscience leave her,' she said. There are millions of Americans facing similar heart-wrenching and financially difficult decisions as America's caregiving crisis is worsening. An astonishing 63 million Americans — nearly 1 in 4 adults — now provide care to an adult with health or functional needs, or to a child with a serious medical condition or disability — a record high, according to a new report from AARP and the National Alliance for Caregiving. That's up from 53 million in 2020 and 43.5 million a decade ago. 'What's even more troubling is what caregiving costs people,' AARP CEO Myechia Minter-Jordan, told Yahoo Finance. Nearly half of caregivers are struggling with significant financial factors. More than 2 in 10 have taken on more debt, about a third have used up short-term savings, 3 in 10 have stopped saving, and roughly 20% are leaving bills unpaid or paying them late, according to the data. At the same time, they are grappling with work and career fall out. More than 60% of caregivers are balancing their caregiving responsibilities while still employed, the report shows. And half report they reduced hours, have taken unpaid leave, or even quit their job entirely as Robinson did. 'There are a number of factors driving the financial strain. It's increasingly challenging for caregivers to access affordable, quality supports and services that are needed to provide adequate care — things such as respite care and access to paid leave from their employers,' Minter-Jordan said. Robinson was initially able to step away from her job temporarily through the Family and Medical Leave Act (FMLA) to see if she might be able to find a way to do both jobs. The FMLA provides 12 weeks a year of unpaid, job-protected leave for specified family and medical reasons with continuation of group health insurance coverage. 'Afterwards, my company wasn't flexible with options and started requiring everybody back into the office,' she said. 'There were not many exceptions granted for working from home. It was just not an environment conducive for me to continue to work.' She's getting by on savings but trying not to tap all of her nest egg. 'I've been living off savings and withdrew a small pension that I had access to, " Robinson said. 'That incremental piece has been a big help with no income coming in.' Unretirement after caregiving Robinson is too young to actually retire for myriad reasons. 'I do know that I will have to return to work at some point to keep up with healthcare costs and increasing cost-of-living,' she said. 'I don't want to deplete my retirement savings. But for now caring for mom is a labor of love. It's just what you do.' To prepare for that future unretirement, she is strategically doing pro bono projects and accepted an unpaid board position on a nonprofit that she can handle remotely — all things that help her skills stay relevant. 'I'm still active so that it won't look to a potential employer that I just went off into vacation mode for a few years and didn't do anything,' she said. The average caregiver is 51 years old and lives with the person they care for, according to the report. Women account for the majority (61%) of caregivers. 'Women face several obstacles that jeopardize their retirement security — they live longer and they need more income,' Cindy Hounsell, founder and president of the Women's Institute for a Secure Retirement (WISER), told Yahoo Finance. 'The impact of caregiving responsibilities causes them to save less, which means recovering financially is unlikely for many of them in this situation.'The workplace dilemma It's not a secret or surprise that caregiving responsibilities hinder career advancement. The work is unpredictable and not responsive to the demands of a 9 to 5 job. As a result, many workers find themselves forced to make career changes. Working caregivers say they are willing to change jobs for better caregiving support — even if it requires a career shift, doing less meaningful work, or relocating, according to a recent SHRM report. Caregivers are often hesitant to even disclose their caregiver status, fearing stigma or negative repercussions in the workplace. 'Caregiving has emerged as one of the most defining challenges facing families, and one of the most disruptive forces shaping the modern workforce,' said Lindsay Jurist-Rosner, CEO and founder of Wellthy, a firm that provides caregiving support through its partnerships with employers, health plans and insurance carriers. I can relate. When I was self-employed a few years ago, I cared for my 91-year-old mother with dementia in my home. I hung by a thread trying to get work done before she awoke for the day. The stress and responsibility were overwhelming. I never told my clients what I was dealing with on a daily basis. I just put my head down and did my work. 'The cost, complexity, and emotional weight of care has only grown, with employees navigating longer lifespans for loved ones, rising care expenses, and increasingly intense responsibilities,' Jusrist-Rosner said. 'Its impact is deeply personal, yet profoundly structural, and it's becoming universal for nearly every employee and every family.' Kerry Hannon is a Senior Columnist at Yahoo Finance. She is a career and retirement strategist and the author of 14 books, including the forthcoming "Retirement Bites: A Gen X Guide to Securing Your Financial Future," "In Control at 50+: How to Succeed in the New World of Work," and "Never Too Old to Get Rich." Follow her on Bluesky. Sign up for the Mind Your Money newsletter Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
